ZOLPIDEM TARTRATE
Generic: ZOLPIDEM TARTRATE
Sandoz IncManufacturer
ORALRoute
ZOLPIDEM TARTRATEActive Substance
2011-07-01Original Approval
ZOLPIDEM TARTRATE is FDA application ANDA090107, sponsored by SANDOZ. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2024-01-18
Zolpidem Tartrate Extended-Release Tablets, USP 12.5mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun PharmaceutiCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufactu
Class II2024-01-18
Zolpidem Tartrate Extended-Release Tablets, USP 6.25 mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun PharmaceutCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufactu
Top Reported Reactions
1
DRUG INEFFECTIVE
1,450 reports
2
NAUSEA
1,242 reports
3
FATIGUE
1,169 reports
4
INSOMNIA
990 reports
5
DIARRHOEA
938 reports
6
FALL
931 reports
7
HEADACHE
917 reports
8
COMPLETED SUICIDE
894 reports
9
PAIN
809 reports
10
VOMITING
805 reports